Peer-influenced content. Sources you trust. No registration required. This is HCN.
ACP Internist
Test your knowledge on the complexities of managing inclusion body myositis, a condition that often shows little improvement with immunosuppressive therapies.
Internal Medicine November 2nd 2023
Medical News Today (MNT)
A recent study involving 4,400 participants revealed that two major statins—rosuvastatin and atorvastatin—are equally effective at reducing heart attacks, strokes, and all-cause deaths. However, it was found that the rosuvastatin group was more likely (7.2%) to develop type 2 diabetes than the atorvastatin group (5.3%).
Cardiology November 2nd 2023
ReachMD
Explore this CME program to gain a deeper understanding of sleep architecture and neurotransmitters. Enhance your practice with this crucial knowledge.
Neurology November 1st 2023
Practical Neurology
The recent study from CTAD 2023 has demonstrated the potential of p-tau217 as a promising biomarker for preclinical Alzheimer’s disease. This finding could significantly enhance our ability to detect Alzheimer’s at its earliest stages and initiate timely interventions.
The New England Journal of Medicine
This case underscores the importance of considering occupational exposure in patients presenting with unexplained neurologic symptoms. The patient’s history as a welder without personal protective equipment was key to diagnosing manganese poisoning – a reminder that sometimes the workplace can be a source of insidious health hazards.
MDLinx
The discovery that chemotherapy-induced cognitive impairment, or “chemobrain,” may be linked to an excess of calcium inside cells opens new avenues for potential therapies. This breakthrough could lead to treatments that restore cognition in patients experiencing these symptoms.